Welcome to our dedicated page for Bridgewater Bancshares SEC filings (Ticker: BWB), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Bridgewater Bancshares, Inc. filings document the regulatory record of a Nasdaq-listed Minnesota financial holding company and its wholly owned banking subsidiary, Bridgewater Bank. Form 8-K reports cover operating results, earnings presentations, Regulation FD investor materials, cash dividend announcements and material agreements such as the company's at-the-market common stock equity distribution arrangement.
Proxy and shareholder-meeting filings address board elections, voting results, executive compensation, equity awards and other governance matters. The filing record also reflects capital-structure disclosures for common stock and depositary-share securities, formal financial-condition disclosures and capital management matters tied to the Bridgewater Bank operating model.
Bridgewater Bancshares (BWB) CEO and director reported an open market sale of 9,439 shares of common stock on 10/28/2025.
The sale was executed at a weighted average price of $17.0094, with individual trades ranging from $17.00 to $17.08. Following the transaction, the reporting person beneficially owned 1,204,922 shares directly. The filing also lists additional indirect holdings as custodian for a child in 1,000‑share entries.
The footnote states the seller will provide full trade‑level details upon request.
Bridgewater Bancshares (BWB) reported higher Q3 results. Net income rose to $11.6 million from $8.7 million a year ago, and diluted EPS increased to $0.38 from $0.27. Net interest income improved to $34.1 million from $25.6 million as loan interest and securities income grew faster than funding costs. The company recorded a $1.1 million provision for credit losses.
Total assets reached $5.36 billion, up from $5.07 billion at year-end. Loans, net, expanded to $4.15 billion from $3.81 billion, while deposits increased to $4.29 billion from $4.09 billion. Securities available for sale were $826.5 million, and accumulated other comprehensive loss narrowed to $5.6 million. The company issued $80.0 million of 7.625% subordinated notes and redeemed $50 million of 5.25% notes. FHLB advances were $404.5 million. Common shares outstanding were 27,584,732 as of October 28, 2025.
Bridgewater Bancshares (BWB) director reported open‑market purchases of common stock. On 10/24/2025, the director bought 16,530 shares at a weighted average price of $17.4439. On 10/27/2025, the director bought 13,470 shares at a weighted average price of $17.4606.
Following these transactions, the director beneficially owned 30,582 shares directly. An additional 298 shares are held indirectly through Volk Advisory Corp.
Bridgewater Bancshares, Inc. (BWB) furnished its Q3 2025 results via a press release and provided an updated investor presentation. The materials were furnished, not filed, under the Exchange Act.
The company also announced a dividend on its 5.875% Non-Cumulative Perpetual Preferred Stock, Series A (Nasdaq: BWBBP). The dividend is $36.72 per preferred share, equivalent to $0.3672 per depositary share (each representing a 1/100th interest), payable on December 1, 2025 to shareholders of record at the close of business on November 14, 2025.
Bridgewater Bancshares Inc. (BWB) Form 4 shows director Jeffrey D. Shellberg reported transactions dated 10/09/2025. The filing records two Code G transactions affecting common stock: a disposition of 54,882 shares and an acquisition of 54,882 shares, both reported with a $0 price, consistent with transfers under a Rule 10b5-1 or similar plan. After the reported activity, Mr. Shellberg directly beneficially owned 289,613 shares and indirectly beneficially owned 372,272 shares through three trusts (holding 87,000, 65,000 and 220,272 implied) for which he has voting and investment power as trustee. The form is signed by an attorney-in-fact on 10/10/2025.
Bridgewater Bancshares Inc. director Lawal Mohammed purchased 1,164 shares of common stock on 09/30/2025 at no stated price, increasing his beneficial ownership to 33,280 shares. The Form 4 was signed on 10/01/2025 by an attorney-in-fact. No derivative transactions or additional details were reported.
Lisa Brezonik, a director of Bridgewater Bancshares Inc (BWB), reported a non-derivative purchase of 1,164 shares of common stock on 09/30/2025. The transaction was recorded at a price of $0 and brings her total reported beneficial ownership to 33,960 shares. The Form 4 filing is signed by an attorney-in-fact on 10/01/2025.
Bridgewater Bancshares Inc (BWB) director Thomas P. Trutna reported a non-derivative acquisition of company stock on 09/30/2025. The Form 4 shows an acquisition of 582 shares with a reported price of $0, resulting in 95,078 shares beneficially owned directly after the transaction. The filing was executed by an attorney-in-fact, Ben Klocke, and dated 10/01/2025.
This disclosure identifies the reporting person as a director and indicates the Form 4 was filed by one reporting person. No derivative transactions or additional explanatory detail are included in the form.
James S. Johnson, a director of Bridgewater Bancshares Inc (BWB), reported an acquisition of 1,164 shares of the company's common stock on 09/30/2025. The Form 4 shows 98,947 shares beneficially owned following the reported transaction on a direct basis. The filing also discloses indirect holdings of 59,250 shares held by the James S. Johnson Trust, 76,750 shares held by the Jolynn Johnson Trust, and 10,417 shares held in a spouse IRA, with shared voting and investment power noted for the trusts. The transaction is recorded at a price of $0 on the form. The form is signed by Ben Klocke, Attorney-in-Fact, dated 10/01/2025.
Bridgewater Bancshares Inc (BWB) director Todd B. Urness reported an open-market purchase of 1,164 shares on 09/30/2025 at no reported cash price, bringing his total beneficial ownership to 1,173,722 shares. The filing was signed by an attorney-in-fact on 10/01/2025. The transaction is recorded on a Form 4 and reflects a director-level acquisition disclosed under Section 16.